March 2015 Research Highlights
In this Breastcancer.org podcast, Dr. Brian Wojciechowski discusses a study looking at whether Zoladex (chemical name: goserelin) given during chemotherapy can help preserve fertility in premenopausal women diagnosed with early-stage, hormone-receptor-negative breast cancer.
Listen to the podcast to hear Dr. Wojciechowski explain:
when Zoladex is given
why women shouldn’t get pregnant while they’re being treated with chemotherapy and Zoladex
why a woman might have to bring this treatment up with her doctor
why this treatment is only recommended for women diagnosed with early-stage, hormone-receptor-negative disease
Dr. Wojo is a medical oncologist outside of Philadelphia, PA, with Crozer Health. His research has been presented at the San Antonio Breast Cancer Symposium, and he is a speaker on medical ethics and the biology of cancer. Dr. Wojo sees cancer as a scientifically complex disease with psychological, social, and spiritual dimensions.
— Last updated on May 2, 2022, 2:44 PM